Found 7 matching trials
A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors
PHASE2The purpose of this study is to determine if it is feasible for women to ta...
Status
Active Not Recruiting
Flibanserin Versus Placebo in Premenopausal Women With HSDD
PHASE3To establish efficacy of Flibanserin 50 Milligrams Daily and 100 Milligrams...
Location
511.77.43005 Boehringer Ingelheim Investigational Site
12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress
PHASE3The current trial will explore the safety of flibanserin in combination wit...
Location
Clinical Innovations
24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
PHASE3This trial is designed to assess the safety and efficacy of flibanserin in ...
Location
511.71.01034 Boehringer Ingelheim Investigational Site
Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America
PHASE3The objective of this trial is to assess the safety and efficacy of 24-week...
Location
511.156.01059 Boehringer Ingelheim Investigational Site
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer
PHASE2This is a double-blinded, placebo-controlled randomized phase II clinical t...
Location
University of Alabama at Birmingham
Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
PHASE3This trial is designed to assess the safety and efficacy of flibanserin in ...
Location
511.75.01015 Boehringer Ingelheim Investigational Site